Quick Answer
TENAX THERAPEUTICS, INC. reported Shares Outstanding of 9.31 million shares for fiscal year 2025.
TENAX THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 9.31M | +172.3% |
| 2024 | 3.42M | +1046.9% |
| 2023 | 298,281 | +941.2% |
| 2022 | 28,648 | -97.7% |
| 2021 | 1.26M | -90.0% |
| 2020 | 12.62M | +87.2% |
| 2019 | 6.74M | +77.8% |
| 2018 | 3.79M | +168.6% |
| 2017 | 1.41M | +0.4% |
| 2016 | 1.41M | -95.0% |
| 2015 | 28.12M | +0.0% |
| 2015 | 28.12M | +0.9% |
| 2014 | 27.86M | +1343.4% |
| 2013 | 1.93M | +31.2% |
| 2012 | 1.47M | -93.7% |
| 2011 | 23.39M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 5.91M | +73.3% | +42.4% |
| June 30, 2025 | 4.15M | +111.8% | +4.5% |
| March 31, 2025 | 3.97M | +102.8% | +16.1% |
| December 31, 2024 | 3.42M | +1046.9% | +0.4% |
| September 30, 2024 | 3.41M | -85.7% | +74.1% |
| June 30, 2024 | 1.96M | -91.8% | +0.0% |
| March 31, 2024 | 1.96M | -91.0% | +556.5% |
| December 31, 2023 | 298,281 | -87.0% | -98.7% |
- TENAX THERAPEUTICS, INC. showed an increase of +172.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, TENAX THERAPEUTICS, INC.’s shares outstanding has declined by 60.2% (from 23.39 million shares to 9.31 million shares).
- The most recent figure is from TENAX THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: